Results 11 to 20 of about 8,290,554 (306)

The impact of pre-operative biologic therapy on post-operative surgical outcomes in ulcerative colitis: a systematic review and meta-analysis

Therapeutic Advances in Gastroenterology, 2020
Background and aims: Biologic therapy has emerged as an effective modality amongst the medical treatment options available for ulcerative colitis (UC). However, its impact on post-operative care in patients with UC is still debatable.
Jasmine Zanelli, Subashini Chandrapalan, Abhilasha Patel, Ramesh P. Arasaradnam   +3 more
doaj   +2 more sources

Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry

European Respiratory Journal, 2023
Background Novel biologic therapies have revolutionised the management of severe asthma with more ambitious treatment aims. Here we analyse the definition of clinical remission as a suggested treatment goal and consider the characteristics associated ...
P. McDowell, Ronald McDowell, John Busby, M. Eastwood, Pujan H. Patel, D. Jackson, Adel H. Mansur, M. Patel, H. Burhan, S. Doe, Rekha Chaudhuri, Robin Gore, J. W. Dodd, D. Subramanian, Thomas Brown, L. Heaney   +15 more
semanticscholar   +1 more source

Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource

Journal of Crohn's & Colitis, 2023
Background and Aims This study compares the effectiveness of different biologic therapies and sequences in patients with inflammatory bowel disease [IBD] using real-world data from a large cohort with long exposure.
C. Kapizioni, R. Desoki, D. Lam, K. Balendran, E. Al-Sulais, S. Subramanian, Joanna E Rimmer, J. De La Revilla Negro, H. Pavey, L. Pele, J. Brooks, G. Moran, P. Irving, J. Limdi, C. Lamb, M. Parkes, T. Raine   +16 more
semanticscholar   +1 more source

Effects of Biologic Therapy on Laboratory Indicators of Cardiometabolic Diseases in Patients with Psoriasis

Journal of Clinical Medicine, 2023
Psoriasis is associated with cardiometabolic and cardiovascular diseases. Biologic therapy targeting tumor necrosis factor (TNF)-α, interleukin (IL)-23, and IL-17 may improve not only psoriasis but also cardiometabolic diseases.
Teppei Hagino, H. Saeki, E. Fujimoto, N. Kanda   +3 more
semanticscholar   +1 more source

Emerging role of dual biologic therapy for the treatment of inflammatory bowel disease

World Journal of Clinical Cases, 2023
Biologic agents have now been used in the management of inflammatory bowel disease (IBD) for many years where experience, expertise and confidence in their use has developed over time.
Matthew McCormack, Natasha A Wahedna, D. Aldulaimi, P. Hawker   +3 more
semanticscholar   +1 more source

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023 - a pragmatic update.

British Journal of Dermatology, 2023
A pragmatic update of the British Association of Dermatologists guidelines for biologic therapy for ...
Catherine H. Smith, Z. Yiu, T. Bale, A. D. Burden, L. Coates, E. Eckert, N. Longley, S. Mahil, A. Mcguire, Ruth Murphy, C. Nelson-Piercy, C. Owen, R. Parslew, R. Woolf, Zahra Mansour Kiaee, Alina M Constantin, M. Ezejimofor, L. Exton, M. Mustapa   +18 more
semanticscholar   +1 more source

Dual Biologic Therapy in Patients with Rheumatoid Arthritis and Psoriatic Arthritis

Rambam Maimonides Medical Journal, 2023
Treatment with biological agents has become standard of care in treatment of immune-mediated diseases (IMD), including rheumatoid arthritis and psoriatic arthritis.
A. Balbir-Gurman, V. Furer, O. Elkayam
semanticscholar   +1 more source

Phage Therapy: From Biologic Mechanisms to Future Directions

Cell, 2023
Increasing antimicrobial resistance rates have revitalized bacteriophage (phage) research, the natural predators of bacteria discovered over one hundred years ago.
S. Strathdee, G. Hatfull, Vivek K. Mutalik, R. Schooley   +3 more
semanticscholar   +1 more source

Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients With Psoriasis at the Individual Level.

JAMA dermatology, 2022
Importance Identifying the optimal long-term biologic therapy for patients with psoriasis is often done through trial and error. Objective To identify the optimal biologic therapy for individual patients with psoriasis using predictive statistical and ...
Mia-Louise Nielsen, T. Petersen, J. Maul, Jashin J. Wu, M. Rasmussen, T. Bertelsen, K. Ajgeiy, L. Skov, S. Thomsen, J. Thyssen, A. Egeberg   +10 more
semanticscholar   +1 more source

Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

Dermatologic Therapy, 2022
The aim of this study was to evaluate response and drug survival of biologic therapy in patients with moderate to severe plaque-type psoriasis who initiated biologic therapy at least 10 years ago, in a real-world setting.
L. Elberdín, R. Fernández-torres, S. Paradela, M. Mateos, Eva Blanco, Vanesa Balboa-Barreiro, M. I. Gómez-Besteiro, M. Outeda, I. Martín‐Herranz, E. Fonseca   +9 more
semanticscholar   +1 more source